Active Ingredient(s): Levamlodipine
FDA Approved: * December 19, 2019
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Conjupri Overview

Levamlodipine (INN), also known as levoamlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine. Amlodipine belongs to the dihydropyridine group of calcium channel blocker used as an antihypertensive and antianginal agent.[1] Levamlodipine is currently marketed in Russia under the brand name EsCordi Cor (Actavis Pharma), in Brazil under the brand name Novanlo (Biolab Sanus) and in India under the trade names Eslo (Zuventus Healthcare Ltd.), Asomex (Em...

Read more Conjupri Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Conjupri Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 1.25mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Conjupri: (6 results)

Sorted by National Drug Code
  • 24075-0410 Conjupri 1.25 mg/1.25mg Oral Tablet by Cspc Ouyi Pharmaceutical Co. Ltd
  • 24075-0411 Conjupri 2.5 mg/2.5mg Oral Tablet by Cspc Ouyi Pharmaceutical Co. Ltd
  • 24075-0412 Conjupri 5 mg/5mg Oral Tablet by Cspc Ouyi Pharmaceutical Co. Ltd
  • 69101-512 Conjupri 1.25 mg Oral Tablet by Burke Therapeutics, LLC
  • 69101-525 Conjupri 2.5 mg Oral Tablet by Burke Therapeutics, LLC
  • 69101-550 Conjupri 5 mg Oral Tablet by Burke Therapeutics, LLC

Other drugs which contain Levamlodipine or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA